BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17357004)

  • 1. Clinicopathological considerations on angiogenic potential in neuroblastoma Schwannian stroma - poor tumours.
    Izycka-Swieszewska E; Drozyńska E; Rzepko R; Dembowska B; Grajkowska W; Brozyna A; Perek D; Balcerska A; Jaśkiewicz K
    Folia Neuropathol; 2007; 45(1):1-8. PubMed ID: 17357004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent microvascular proliferation in clinically aggressive neuroblastoma.
    Peddinti R; Zeine R; Luca D; Seshadri R; Chlenski A; Cole K; Pawel B; Salwen HR; Maris JM; Cohn SL
    Clin Cancer Res; 2007 Jun; 13(12):3499-506. PubMed ID: 17575212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
    Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
    Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of microvascular density and the expression of vascular-endothelial growth factor (VEGF) and its membrane receptor Flk-1 in neuroblastoma].
    Drozyńska E; Izycka-Swieszewska E; Balcerska A; Bodalski J; Bohosiewicz J; Brozyna A; Bubała H; Chybicka A; Grajkowska W; Koltan S; Madziara W; Rybczyńska A; Słociak M; Sońta-Jakimczyk D; Stolarska M; Perek D; Wachowiak J; Wysocki M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):745-55. PubMed ID: 17317905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
    Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
    J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
    Hu HL; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
    Zeine R; Salwen HR; Peddinti R; Tian Y; Guerrero L; Yang Q; Chlenski A; Cohn SL
    Mod Pathol; 2009 Jul; 22(7):950-8. PubMed ID: 19407854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
    Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S
    J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
    Yco LP; Geerts D; Koster J; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
    Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
    Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
    Meitar D; Crawford SE; Rademaker AW; Cohn SL
    J Clin Oncol; 1996 Feb; 14(2):405-14. PubMed ID: 8636750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
    Sköldenberg EG; Larsson A; Jakobson A; Hedborg F; Kogner P; Christofferson RH; Azarbayjani F
    Anticancer Res; 2009 Aug; 29(8):3311-9. PubMed ID: 19661350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
    Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
    J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
    Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor origin of endothelial cells in human neuroblastoma.
    Pezzolo A; Parodi F; Corrias MV; Cinti R; Gambini C; Pistoia V
    J Clin Oncol; 2007 Feb; 25(4):376-83. PubMed ID: 17264333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.
    Darwish MH; Farah RA; Farhat GN; Torbey PH; Ghandour FA; Bejjani-Doueihy NA; Dhaini HR
    Mol Med Rep; 2015 Feb; 11(2):1462-8. PubMed ID: 25370902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.